Mediolanum International Funds Ltd Raises Stock Holdings in Cigna Group $CI

Mediolanum International Funds Ltd boosted its position in Cigna Group (NYSE:CIFree Report) by 4.5% in the first quarter, Holdings Channel.com reports. The firm owned 103,764 shares of the health services provider’s stock after buying an additional 4,499 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Cigna Group were worth $26,779,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. apricus wealth LLC lifted its holdings in shares of Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after purchasing an additional 8,340 shares during the last quarter. Wilsey Asset Management Inc. grew its stake in shares of Cigna Group by 5.1% in the 4th quarter. Wilsey Asset Management Inc. now owns 110,801 shares of the health services provider’s stock worth $30,496,000 after buying an additional 5,327 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Cigna Group by 3.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock worth $29,046,000 after buying an additional 3,814 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in Cigna Group by 4.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 95,023 shares of the health services provider’s stock valued at $27,068,000 after buying an additional 4,394 shares in the last quarter. Finally, Swiss Life Asset Management Ltd increased its position in Cigna Group by 13.1% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 43,367 shares of the health services provider’s stock valued at $12,501,000 after buying an additional 5,033 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $281.72 on Friday. The firm has a market cap of $74.52 billion, a P/E ratio of 11.94, a PEG ratio of 1.08 and a beta of 0.29. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50 day moving average of $286.68 and a 200 day moving average of $280.40.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Royal Bank Of Canada boosted their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Guggenheim raised their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Raymond James Financial set a $340.00 price target on Cigna Group in a research report on Friday, May 1st. Mizuho upped their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Piper Sandler cut their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $338.80.

Check Out Our Latest Stock Analysis on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.